Skip to main content

Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass



Sphincter of Oddi dysfunction (SOD) is thought to be a cause of chronic abdominal pain post Roux-en-Y gastric bypass, and current practice of performing endoscopic retrograde cholangiopancreatography (ERCP) with or without sphincterotomy is not supported by evidence. In addition to the complexity and risks of the procedure in patients with Roux-en-Y anatomy, the outcomes are uncertain and debatable. We performed a retrospective review and analysis of post-gastric bypass patients who had undergone ERCP with sphincterotomy to determine the effectiveness in patients with suspected SOD.


Over a period of 5 years at the University of Minnesota, we retrospectively reviewed a prospectively collected database of a cohort of patients whom had a previous Roux-en-Y gastric bypass and whom had a subsequent ERCP for suspected SOD. Patients were categorized by modified Milwaukee classification, and outcomes were evaluated by patients’ self-reporting of symptoms at follow-up.


We identified 50 patients who underwent laparoscopic-assisted gastrostomy for endoscopic retrograde cholangiopancreatography post Roux-en-Y gastric bypass over the study period. Within this group, 35 patients (70%) were suspected to have SOD. Nine patients (25.7%) were classified as type I, 19 patients (54.3%) type II, and seven patients (20%) type III. Thirty-four patients (97.1%) had biliary sphincterotomy, and 17 patients (48.6%) had both biliary and pancreatic sphincterotomy. Fourteen (40%) had repeated ERCP. At median follow-up of 11.5 months, type I SOD had two responders (25%), type II had nine responders (52.9%), and type III had one responder (14.3%). A subgroup analysis did not show significant differences in improvement of symptoms between patients whom had single versus repeated ERCP or biliary sphincterotomy alone versus both biliary and pancreatic sphincterotomy. Three patients (9%) had post-ERCP pancreatitis.


SOD in patients post Roux-en-Y gastric bypass is complex due to multiple confounding factors. Rome III and Milwaukee classification systems assist us in the diagnosis and treatment of sphincter dysfunction until we have a better way to predict treatment response post sphincterotomy. Current treatment is based on the type of disorder and anatomy of biliary ducts. Types I and II sphincter dysfunction particularly associated with dilated biliary duct on imaging have the best response to endoscopic sphincterotomy and therefore should be considered taking into account the risks and benefit. Repeated sphincterotomy and concurrent pancreatic sphincterotomy is generally not useful.

This is a preview of subscription content, access via your institution.

Fig. 1
Fig. 2
Fig. 3
Fig. 4
Fig. 5


  1. Angrisani L, Santonicola A, Iovino P, et al. Bariatric surgery worldwide 2013. Obes Surg. 2015;25(10):1822–32.

    CAS  Article  PubMed  Google Scholar 

  2. Cho M, Kaidar-Person O, Szomstein S, et al. Emergency room visits after laparoscopic Roux-en-Y gastric bypass for morbid obesity. Surg Obes Relat Dis. 2008;4(2):104–9.

    Article  PubMed  Google Scholar 

  3. Saunders J, Ballantyne GH, Belsley S, et al. One-year readmission rates at a high volume bariatric surgery center: laparoscopic adjustable gastric banding, laparoscopic gastric bypass, and vertical banded gastroplasty-Roux-en-Y gastric bypass. Obes Surg. 2008;18(10):1233–40.

    Article  PubMed  Google Scholar 

  4. Kellogg TA, Swan T, Leslie DA, et al. Patterns of readmission and reoperation within 90 days after Roux-en-Y gastric bypass. Surg Obes Rel Dis. 2009;5(4):416–23.

    Article  Google Scholar 

  5. Swartz DE, Mobley E, Felix EL. Bile reflux after Roux-en-Y gastric bypass: an unrecognized cause of postoperative pain. Surg Obes Relat Dis. 2009;5(1):27–30.

    Article  PubMed  Google Scholar 

  6. Bal B, Shope T, Finelli FC, et al. Pravalence and causes of abdominal pain following fully divided Roux-en-Y gastric bypass surgery. 2011;2:187.

  7. Drossman DA, Li Z, Andruzzi E, et al. US householder survey of functional gastrointestinal disorders. Prevalence, sociodemographic, and health impact. Dig Dis Sci. 1993;38:1569–80.

    CAS  Article  PubMed  Google Scholar 

  8. Bar-Meir S, Halpern Z, Bardan E, et al. Frequency of papillary dysfunction among cholecystectomized patients. Hepatomogy. 1984;4:328–30.

    CAS  Google Scholar 

  9. Matlock J, Ikramuddin S, Lederer H, et al. Bypassing the bypass: ERCP via gastrostomy after bariatric surgery. GI Endo. 2005;61(5):98.

    Google Scholar 

  10. Gutierrez JM, Lederer H, Krook JC, et al. Surgical gastrostomy for pancreatobiliary and duodenal access following Roux-en-Y gastric bypass. J Gastrointest Surg. 2009;13:2170–5.

    Article  PubMed  Google Scholar 

  11. Drossman DA. Moderator. AGA clinical symposium—Rome III: new criteria for the functional GI disorders. Los Angeles: Program and abstracts of Digestive Disease Week; May 20–25; 2006.

    Google Scholar 

  12. Geenen JE, Hogan WJ, Dodds WJ, et al. The efficacy of endoscopic sphincterotomy after cholecystectomy in patients with sphichter of Oddi dysfunction. New Engl J Med. 1989;320:82–7.

    CAS  Article  PubMed  Google Scholar 

  13. Peterson BT. Sphincter of Oddi dysfunction, part 2: evidence based review of the presentations, with “objective” pancreatic findings (types I and II) and of presumptive type III. Gastrointest Endosc. 2004;59:670–86.

    Article  Google Scholar 

  14. Cohen S, Bacon BR, Berlin JA, et al. National Institutes of Health state of the science conference statement: ERCP for diagnosis and therapy. Gastrointest Endosc. 2002;56:803–9.

    Article  PubMed  Google Scholar 

  15. Kalarchian MA, Marcus MD, Levine MD, et al. Psychiatric disorders among bariatric surgery candidates: relationship to obesity and functional health status. Am J Psychiatry. 2007;164:328–34.

    Article  PubMed  Google Scholar 

  16. Lin HY, Huang CK, Tai CM, et al. Psychiatric disorders of patients seeking obesity treatment. BMC Psychiatry. 2013;13:1.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  17. Hayden MJ, Murphy KD, Brown WA, et al. Axis I disorders in adjustable gastric band patients: the relationship between psychopathology and weight loss. Obes Surg. 2014;24(9):1469–75.

    CAS  Article  PubMed  Google Scholar 

  18. Malik S, Mitchell JE, Engel S, et al. Psychopathology in bariatric surgery candidates: a review of studies using structured diagnostic interviews. Compr Psychiatry. 2014;55:248–59.

    Article  PubMed  Google Scholar 

  19. Vitton V, Delpy R, Lesavre N, et al. Is endoscopic sphincterotomy avoidable in patients with sphincter of Oddi dysfunction? Eur J Gastroenterol Hepatol. 2008;20(1):15–21.

    Article  PubMed  Google Scholar 

  20. Khuroo MS, Zargar SA, Yattoo GN. Efficacy of nifedipine therapy in patients with sphincter of Oddi dysfunction: a prospective, double-blind, randomized, placebo-controlled, cross over trial. Br J Clin Pharmacol. 1992;33(5):477–85.

  21. Sand J, Nordback I, Koskinen M, et al. Nifedipine for suspected type II sphincter of Oddi dyskinesia. Am J Gastroenterol. 1993;88(4):530–5.

  22. Hall TC, Dennison AR, Garcea G. The diagnosis and management of Sphincter of Oddi dysfunction: a systemic review. Langenbecks Arch Surg. 2012;397(6):889–98

  23. Rolny P, Geenen JE, Hogan WJ. Post-cholecystectomy patients with “objective signs” of partial bile outflow obstruction: clinical characteristics, sphincter of Oddi manometry findings, and results of therapy. Gastrointest Endosc. 1993;39(6):778–81.

    CAS  Article  PubMed  Google Scholar 

  24. Thatcher BS, Sivak MV, Tedesco FJ, et al. Endoscopic sphincterotomy for suspected dysfunction of the sphincter of Oddi. Gastrointest Endosc. 1987;33(2):91–5.

    CAS  Article  PubMed  Google Scholar 

  25. Cotton PB, Durkalski V, Romagnuolo J, et al. Effect of endoscopic sphincterotomy for suspected sphincter of Oddi dysfunction on pain-related disability following cholecystectomy: the EPISODE randomized clinical trial. JAMA. 2014;311(1):2101–9.

    CAS  Article  PubMed  PubMed Central  Google Scholar 

  26. Morgan KA, Glenn JB, Byrne K, et al. Sphincter of Oddi dysfunction after Roux-en-Y gastric bypass. Surg Obes Real Dis. 2009;5:571–5.

    Article  Google Scholar 

  27. Freeman ML, Gill M, Overby C, et al. Predictors of outcomes after biliary and pancreatic sphincterotomy for sphincter of oddi dysfunction. J Clin Gastroenterol. 2007;41(1):94–102.

    Article  PubMed  Google Scholar 

  28. Grimes KL, Maciel VH, Mata W, et al. Complications of laparoscopic transgastric ERCP in patients with Roux-en-Y gastric bypass. Surg Endosc. 2015;29:1753–9.

    Article  PubMed  Google Scholar 

  29. Saleem A, Levy MJ, Petersen BT, et al. Laparoscopic assisted ERCP in Roux-en-Y gastric bypass (RYGB) surgery patients. J Gastrointest Surg. 2012;16(1):203–8.

    Article  PubMed  Google Scholar 

Download references

Author information

Authors and Affiliations


Corresponding author

Correspondence to Chin Hong Lim.

Ethics declarations

This study was approved by the respective Institutional Review Board of our center.

Conflict of Interest

The authors declare that they have no conflict of interests.

Informed Consent

Informed consent was obtained from all individual participants included in the study.

Rights and permissions

Reprints and Permissions

About this article

Verify currency and authenticity via CrossMark

Cite this article

Lim, C.H., Jahansouz, C., Freeman, M.L. et al. Outcomes of Endoscopic Retrograde Cholangiopancreatography (ERCP) and Sphincterotomy for Suspected Sphincter of Oddi Dysfunction (SOD) Post Roux-En-Y Gastric Bypass. OBES SURG 27, 2656–2662 (2017).

Download citation

  • Published:

  • Issue Date:

  • DOI:


  • Endoscopic retrograde cholangiopancreatography
  • Sphincter of oddi dysfunction
  • Sphincterotomy
  • Roux-en-Y gastric bypass
  • Pancreatitis